In a remarkable scientific breakthrough that researchers are calling a ‘eureka moment,’ a team at the University of Cambridge ...

The research team discovered that platelets release a substance called thromboxane A2 (TXA2), which attaches to receptors on T cells and activates a protein called ARHGEF1. This interaction suppresses ...

Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...

Essentially, aspirin can boost the immune system’s ability to fight cancer metastasis by stopping platelets — tiny blood ...

Scientists found that aspirin blocks TXA2, freeing T cells to fight cancer. This discovery could help prevent metastasis, but ...

The new research suggests a path for aspirin to become a cancer treatment - but people are being warned not to start taking ...

As researchers explain in a release from the University of Cambridge, aspirin can reduce a clotting factor known as thromboxane A2 (TXA2). But a side effect of this clotting factor is that it ...

Through a mouse study, scientists have found that aspirin may help prevent metastases, or secondary tumors, by boosting the body’s immune response.

Scientists share how they discovered that aspirin could potentially help to prevent cancer spread in the body.

The anti-clotting effect of aspirin may trigger a biological chain of events that stops cancer cells from metastasizing, ...